The management of antithrombotic agents for patients undergoing GI endoscopy

Gastrointestinal Endoscopy

Volumn 83, Issue 1, 2016, Pages 3-16

  Acosta, Ruben D ^a   Abraham, Neena S ^a   Chandrasekhara, Vinay ^a   Chathadi, Krishnavel V ^a   Early, Dayna S ^a   Eloubeidi, Mohamad A ^a   Evans, John A ^a   Faulx, Ashley L ^a   Fisher, Deborah A ^a   Fonkalsrud, Lisa ^a   Hwang, Joo Ha ^a   Khashab, Mouen A ^a   Lightdale, Jenifer R ^a   Muthusamy, V Raman ^a   Pasha, Shabana F ^a   Saltzman, John R ^a   Shaukat, Aasma ^a   Shergill, Amandeep K ^a   Wang, Amy ^a   Cash, Brooks D ^a   DeWitt, John M ^a   more..

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; FIBRINOLYTIC AGENT;

BLOOD LOSS, SURGICAL; CHEMICALLY INDUCED; GASTROINTESTINAL ENDOSCOPY; HUMAN; POSTOPERATIVE HEMORRHAGE; PRACTICE GUIDELINE; PROCEDURES;

ANTICOAGULANTS; BLOOD LOSS, SURGICAL; ENDOSCOPY, GASTROINTESTINAL; FIBRINOLYTIC AGENTS; HUMANS; PLATELET AGGREGATION INHIBITORS; POSTOPERATIVE HEMORRHAGE;

EID: 84952361472     PISSN: 00165107     EISSN: 10976779     Source Type: Journal    
DOI: 10.1016/j.gie.2015.09.035     Document Type: Article

References (116)

1. G. Guyatt, A.D. Oxman, E.A. Akl, and et al. GRADE guidelines: introduction-GRADE evidence profiles and summary of findings tables J Clin Epidemiol 64 2011 383 394
2. N.S. Abraham, C. Hartman, P. Richardson, and et al. Risk of lower and upper gastrointestinal bleeding, transfusions, and hospitalizations with complex antithrombotic therapy in elderly patients Circulation 128 2013 1869 1877
3. I.L. Holster, V.E. Valkhoff, E.J. Kuipers, and et al. New oral antigcoagulants increase risk for gastrointestinal bleeding: a systematic review and meta-analysis Gastroenterology 145 1 2013 105 112.e15
4. H. Jneid, J.L. Anderson, R.S. Wright, and et al. 2012 ACCF/AHA Focused update of the guideline for the management of patients with unstable angina/non-ST-elevation myocardial infarction (updating the 2007 guideline and replacing the 2011 focused update) JACC 60 2012 645 681
5. L. Wallentin, R.C. Becker, A. Budaj, and et al. Ticagrelor versus clopidogrel in patients with acute coronary syndromes N Engl J Med 361 2009 1045 1057
6. S.D. Wiviott, E. Braunwald, C.H. McCabe, and et al. Prasugrel versus clopidogrel in patients with acute coronary syndromes N Engl J Med 357 2007 2001 2015
7. N.S. Abraham, and D.L. Castillo Novel anticoagulants: bleeding risk and management strategies Curr Opin Gastroneterol 29 2013 676 683
8. ASGE Standards of Practice committee M.A. Anderson, T. Ben-Menachem, S.I. Gan, and et al. Management of antithrombotic agents for endoscopic procedures Gastrointest Endosc 70 2009 1060 1070
9. J.C. Perreira-Lima, R.P. Ramires, I. Zamin, and et al. Endoscopic dilation of benign esophageal strictures: report on 1043 procedures Am J Gastroenterol 94 1999 1497 1501
10. R. Raymond, J.C. Perreira-Lima, A. Valves, and et al. Endoscopic dilation of benign esophageal strictures without fluoroscopy: experience of 2750 procedures Hepatogastroenterology 55 2008 1342 1348
11. L. Polese, I. Angriman, E. Bonello, and et al. Endoscopic dilation of benign esophageal strictures in a surgical unit: a report on 95 cases Surg Laparosc Endosc Percutan Tech 17 2007 477 481
12. ASGE Standards of Practice committee G.M. Eisen, T.H. Baron, J.A. Dominitz, and et al. Guideline on the management of anticoagulation and antiplatelet therapy for endoscopic procedures Gastrointest Endosc 55 2002 775 779
13. P.H. Rubin, and J.D. Waye Colonoscopic polypectomy: a critical review of recent literature Curr Gastroenterol Rep 8 2006 430 433
14. S. Vatansever, Z. Akpinar, E. Alper, and et al. Gastric polyps and polypoid lesions: Retrospective analysis of 36650 endoscopic procedures in 29940 patients Turk J Gastroenterol 26 2015 117 122
15. P.B. Mensink, J. Haringsma, T. Kuchrzik, and et al. Complications of double balloon enteroscopy: a multicenter survey Endoscopy 39 2007 613 615
16. A. May, L. Nachbar, J. Pohl, and et al. Endoscopic interventions in the small bowel using double balloon enteroscopy: feasibility and limitations Am J Gastroenterol 102 2007 527 535
17. P.B. Cotton, D.A. Garrow, J. Gallagher, and et al. Risk factors for complications after ERCP: a multivariate analysis of 11,497 procedures over 12 years Gastrointest Endosc 70 2009 80 88
18. A. Horiuchi, Y. Nakayama, N. Tanaka, and et al. Prospective randomized trial comparing the direct method using a 24 Fr bumper-button-type device with the pull method for percutaneous endoscopic gastrostomy Endoscopy 40 2008 722 726
19. A.A. Rahnemai-Azar, A.A. Rahnemaiazar, R. Naghshizadian, and et al. Percutaneous endoscopic gastrostomy: indications, technique and management World J Gastroenterol 20 2014 7739 7751
20. S.P. Lee, K.N. Lee, O.Y. Lee, and et al. Risk factors for complications of percutaneous endoscopic gastrostomy Dig Dis Sci 59 2014 117 125
21. Y. Zopf, C. Rabe, T. Bruckmoser, and et al. Percutaneous endoscopic jejunostomy and jejunal extension tube through percutaneous endoscopic gastrostomy: a retrospective analysis of success, complications and outcome Digestion 79 2009 92 97
22. R.A. Kozarek Endoscopic palliation of esophageal malignancy Endoscopy 35 2003 S9 13
23. Y. Cao, C. Liao, A. Tan, and et al. Meta-analysis of endoscopic submucosal dissection versus endoscopic mucosal resection for tumors of the gastrointestinal tract Endoscopy 41 2009 751 757
24. D. Heresbach, R. Kornhauser, J.A. Seyrig, and et al. A national survey of endoscopic mucosal resection for superficial gastrointestinal neoplasia Endoscopy 42 2010 806 813
25. K.L. Lynch, J.E. Pandolfino, C.W. Howden, and et al. Major complications of pneumatic dilation and Heller myotomy for achalasia: single center experience and systematic review of the literature Am J Gastroenterol 107 2012 1817 1825
26. G. Pai, Cipolleta, M. Claar, and et al. Prophylactic sclerotherapy of high risk esophageal varices: results of a multicentric prospective controlled trial Hepatology 8 1988 1495 1500
27. M.Y. Cai, P.H. Zhou, L.Q. Yao, and et al. Peroral endoscopic myotomy for idiopathic achalasia: randomized comparison of water-jet assisted versus conventional dissection technique Surg Endosc 28 2014 1158 1165
28. C. Fabbri, C. Luigiano, A. Maimone, and et al. Endoscopic ultrasound-guided drainage of pancreatic fluid collections World J Gastrointest Endosc 4 2012 479 488
29. D.A. Katzka, and T.H. Baron Transoral flexible endoscopic therapy of Zenker's diverticulum: is it time for gastroenterologists to stick their necks out? Gastrointest Endosc 77 2013 708 710
30. R.A. Kozarek, T.J. Ball, J.J. Branbaur, and et al. Expandable versus conventional esophageal prostheses: easier insertion may not preclude subsequent stent-related problems Gastrointest Endosc 43 1996 204 208
31. A. Dormann, S. Meisner, N. Verin, and et al. Self-expanding stents for gastroduodenal malignancies: systematic review of clinical effectiveness Endoscopy 36 2004 543 550
32. J.J. Telford, D.L. Carr-Locke, T.H. Baron, and et al. Palliation of patients with malignant gastric outlet obstruction with the enteral Wallstent: outcomes from a multicenter study Gastrointest Endosc 60 2004 916 920
33. G.Y. Lip, R. Nieuwlaat, R. Pisters, and et al. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the Euro Heart Survey on atrial fibrillation Chest 137 2010 263 272
34. J.W. van Werkum, A.A.C.M. Heestermans, F.I. de Korte, and et al. Long-term clinical outcome after a first angiographically confirmed coronary stent thrombosis, an analysis of 431 cases Circulation 119 2009 828 834
35. J. Daemen, P. Wenaweser, K. Tsuchida, and et al. Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study Lancet 369 2007 667 678
36. R.C. Becker, J. Scheiman, H.L. Dauerman, and et al. Management of platelet-directed pharmacotherapy in patients with atherosclerotic coronary artery disease undergoing elective endoscopic gastrointestinal procedures Am J Gastroenterol 104 2009 2903 2917
37. J.D. Douketis, A.C. Spyropoulos, F.A. Spencer, and et al. Perioperative management of antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines Chest 141 2 Suppl 2012 e326S e350S
38. R.B. D'Agostino, R.S. Vasan, M.J. Pencina, and et al. General cardiovascular risk profile for use in primary care: the Framingham Heart Study Circulation 117 2008 743 753
39. C. Patrono, G. Ciabattoni, P. Patrignani, and et al. Clinical pharmacology of platelet cyclooxygenase inhibition Circulation 72 1985 1177 1184
40. G. Born, and C. Patrono Antiplatelet drugs Br J Pharmacol 147 Suppl 1 2006 S241 S251
41. T. Simon, C. Verstuyft, M. Mary-Krause, and et al. Genetic determinants of response to clopidogrel and cardiovascular events N Engl J Med 360 2009 363 375
42. G. Cayla, J.S. Hulot, S.A. O'Connor, and et al. Clinical, angiographic, and genetic factors associated with early coronary stent thrombosis JAMA 306 2011 1765 1774
43. V.L. Serebuany, S.R. Steinhubl, P.B. Berger, and et al. Variability in platelet responsiveness to clopidogrel among 544 individuals J Am Coll Cardiol 45 2005 246 251
44. I. Muller, F. Besta, C. Shulz, and et al. Prevalence of clopidogrel nonresponders among patients with stable angina pectoris scheduled for elective coronary stent placement Thromb Haemost 89 2003 783 787
45. S. Matetzky, B. Shenkman, V. Guetta, and et al. Clopidogrel resistance is associated with increased risk of recurrent atherothrombotic events in patients with acute myocardial infarction Circulation 109 2004 3171 3175
46. S.D. Wiviott, T. Trenk, A.L. Frelinger, and et al. Prasugrel compared with high loading-and maintenance-dose clopidogrel in patients with planned percutaneous coronary intervention, the prasugrel in comparison to clopidogrel for inhibition of platelet activation and aggregation - thrombolysis in myocardial infarction 44 trial Circulation 116 2007 2923 2932
47. K.P. Bliden, U.S. Tantry, R.F. Storey, and et al. The effect of ticagrelor versus clopidogrel on high on-treatment platelet reactivity: combined analysis of the ONSET/OFFSET and RESPOND studies Am Heart J 162 2011 160 165
48. G. Cayla, J. Silvain, S.A. O'Connor, and et al. Current antiplatelet options for NSTE-ACS patients Q J Med 105 2012 935 948
49. P.A. Gurbel, K.P. Bliden, K. Butler, and et al. Randomized double-blind assessment of the ONSET and OFFSET of the antiplatelet effects of ticagrelor versus clopidogrel in patients with stable coronary artery disease: the ONSET/OFFSET study Circulation 120 2009 2577 2585
50. D.A. Morrow, E. Braunwald, M.P. Bonaca, and et al. Vorapaxar in the secondary prevention of atherothrombotic events N Engl J Med 366 2012 1404 1413
51. M. Ueno, J.L. Ferreiro, and D.J. Angiolillo Mechanism of action and clinical development of platelet thrombin receptor antagonists Exp Rev Cardiovasc Ther 8 2010 1191 1200
52. S. Schulman, R. Elbazi, M. Zondag, and et al. Clinical factors influencing the normalization of prothrombin time after stopping warfarin: a retrospective cohort study Thromb J 16 2008 15
53. J.I. Weitz, D.J. Quinlan, and J.W. Eikelboom Periprocedural management and approach to bleeding in patients taking dabigatran Circulation 126 2012 2428 2432
54. W.S. Dzik Reversal of drug-induced anticoagulation: old solutions and new problems Transfusion 52 Suppl 1 2012 25S 55S
55. FDA approves Praxbind, the first reversal agent for the anticoagulant Pradaxa. Available at: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm467300.htm. Accessed October 15, 2015.
56. J.E. Ansell, S.H. Bakhru, B.E. Laulicht, and et al. Use of PER977 to reverse the anticoagulant effect of edoxaban N Engl J Med 371 2014 2141 2142
57. M. Crowther, M. Kitt, T. Lorenz, and et al. A phase 2 randomized, double-blind, placebo-controlled trial of PRT064445, a novel, universal antidote for direct and indirect factor Xa inhibitors J Thromb Haemost 11 2013 30
58. M. Landenhed, M. Johansson, D. Erlinge, and et al. Fondaparinux or enoxaparin: a comparative study of postoperative bleeding in coronary artery bypass grafting surgery Scand Cardiovasc J 44 2010 100 106
59. T.H. Baron, P.S. Kamath, and R.D. McBane Management of antithrombotic therapy in patients undergoing invasive procedures N Engl J Med 368 2013 2113 2124
60. D.L. Bhatt, J.S. Hulot, D.J. Moliterno, and et al. Antiplatelet and anticoagulation therapy for acute coronary syndromes Circ Res 114 2014 1929 1943
61. A. Horiuchi, Y. Nakayama, M. Kajiyama, and et al. Removal of small colorectal polyps in anticoagulated patients: a prospective randomized comparison of cold snare and conventional polypectomy Gastrointest Endosc 79 2014 417 423
62. D.O. Williams, J.D. Abbott, and L.E. Kip DEScover Investigators. Outcomes of 6905 patients undergoing percutaneous coronary intervention in the era of drug-eluting stents: report of the DEScover Registry Circulation 114 2006 2154 2162
63. I. Iakovou, T. Schmidt, E. Bonizzoni, and et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents JAMA 293 2005 2126 2130
64. L. Mauri, W.H. Hsieh, J.M. Massaro, and et al. Stent thrombosis in randomized clinical trials of drug-eluting stents N Engl J Med 356 2007 1020 1029
65. D.A. Garcia, S. Regan, L.E. Henault, and et al. Risk of thromboembolism with short-term interruption of warfarin therapy Arch Intern Med 168 2008 63 69
66. D.J. Blacker, E.F. Wijdicks, and R.L. McLelland Stroke risk in anticoagulated patients with atrial fibrillation undergoing endoscopy Neurology 61 2003 964 968
67. D.M. Witt, T. Delate, D.A. Garcia, and et al. Risk of thromboembolism, recurrent hemorrhage, and death after warfarin therapy interruption for gastrointestinal tract bleeding Arch Intern Med 172 2012 1484 1491
68. M. Constans, A. Santamaria, J. Mateo, and et al. Low-molecular-weight heparin as bridging therapy during interruption of oral anticoagulation in patients undergoing colonoscopy or gastroscopy Int J Clin Pract 61 2007 212 217
69. C.T. January, L.S. Wann, J.S. Alpert, and et al. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation J Am Coll Cardiol 64 2014 e1 76
70. R.A. Nishimura, C.M. Otto, R.O. Bonow, and et al. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines Circulation 129 2014 e521 643
71. D. Siegal, J. Yudin, S. Kaatz, and et al. Periprocedural heparin bridging in patients receiving vitamin K antagonists Circulation 126 2012 1630 1639
72. J.D. Douketis, A.C. Spyropoulos, S. Kaatz, and et al. Perioperative bridging anticoagulation in patients with atrial fibrillation N Engl J Med 373 2015 823 833
73. M.J. Eisenberg, P.R. Richard, D. Libersan, and et al. Safety of short-term discontinuation of antiplatelet therapy in patients with drug-eluting stents Circulation 119 2009 1634 1642
74. D.L. Bhatt, J. Scheiman, N.S. Abraham, and et al. ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use Circulation 118 2008 1894 1909
75. S.K. Timothy, T.C. Hicks, F.G. Opelka, and et al. Colonoscopy in the patient requiring anticoagulation Dis Colon Rectum 44 2001 1845 1848 discussion, 1848-9
76. M.S. Sawhney, N. Salfiti, D.B. Nelson, and et al. Risk factors for severe delayed postpolypectomy bleeding Endoscopy 40 2008 115 119
77. A.S. Taha, W.J. Angerson, R.P. Knill-Jones, and et al. Upper gastrointestinal mucosal abnormalities and blood loss complicating low-dose aspirin and antithrombotic therapy Aliment Pharmacol Ther 23 2006 489 495
78. J.G. Hashash, W. Shamseddeedn, A. Skoury, and et al. Gross lower gastrointestinal bleeding in patients on anticoagulant and/or antiplatelet therapy: endoscopic findings, management, and clinical outcomes J Clin Gastroenterol 43 2009 36 42
79. T.A. Rubin, M. Murdoch, and D.B. Nelson Acute GI bleeding in the setting of supratherapeutic international normalized ratio in patients taking warfarin: endoscopic diagnosis, clinical management, and outcomes Gastrointest Endosc 58 2008 369 373
80. C.P. Choudari, C. Rajgopal, and K.R. Palmer Acute gastrointestinal haemorrhage in anticoagulated patients: diagnoses and response to endoscopic treatment Gut 35 1994 464 466
81. A.T. Wolf, S.K. Wasan, and J.R. Saltzman Impact of anticoagulation on rebleeding following endoscopic therapy for nonvariceal upper gastrointestinal hemorrhage Am J Gastroenterol 102 2007 290 296
82. A. Shingina, A.N. Barkun, A. Razzaghi, and et al. Systematic review: the presenting international normalized ratio (INR) as a predictor of outcome in patients with upper nonvariceal gastrointestinal bleeding Aliment Pharmacol Ther 33 2011 1010 1018
83. S.K. Kuwada, R. Balm, and C.J. Gostout The role of withdrawing chronic antithrombotic because of acute GI bleeding Am J Gastroenterol 91 1996 1116 1119
84. K. Ananthasubramaniam, J.N. Beattie, H.S. Rosman, and et al. How safely and how long can warfarin therapy be withheld in prosthetic heart valve patients hospitalized with a major hemorrhage? Chest 119 2001 478 484
85. A. Holbrook, S. Schulman, D.M. Witt, and et al. Evidence-based management of anticoagulant therapy: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines Chest 141 2012 e152S e184S
86. R. Sarode, K. Matevosyan, R. Bhagat, and et al. Rapid warfarin reversal: a 3-factor prothrombin complex concentrate and recombinant factor VIIa cocktail for intracerebral hemorrhage J Neurosurg 116 2012 491 497
87. S. Kaatz, P.A. Kouides, D.A. Garcia, and et al. Guidance on the emergent reversal of oral thrombin and factor Xa inhibitors Am J Hematol 87 Suppl 1 2012 S141 S145
88. F.K. Chan, J.Y. Ching, L.C. Hung, and et al. Clopidogrel versus aspirin and esomeprazole to prevent recurrent ulcer bleeding N Engl J Med 102 2005 290 296
89. K.C. Lai, K.M. Chu, W.M. Hui, and et al. Esomeprazole with aspirin versus clopidogrel for prevention of recurrent gastrointestinal ulcer complications Clin Gastroenterol Hepatol 4 2006 860 865
90. J.J.Y. Sung, J.Y.W. Lau, J.Y.L. Ching, and et al. Continuation of low-dose aspirin therapy in peptic ulcer bleeding Ann Intern Med 152 2010 1 9
91. J. Hallas, M. Dall, A. Andries, and et al. Use of single and combined antithrombotic therapy and risk of serious upper gastrointestinal bleeding: population based case-control study BMJ 333 2006 726
92. M. Moscucci, K.A. Fox, and et al. Predictors of major bleeding in acute coronary syndromes; the Global Registry of Acute Coronary Events (GRACE) Eur Heart J 24 2003 1815 1823
93. M. Al-Mallah, R.N. Bazari, M. Jankowski, and et al. Predictors and outcomes associated with gastrointestinal bleeding in patients with acute coronary syndromes J Thromb Thrombo 23 2007 51 55
94. A.E. Abbas, B. Brodie, S. Dixon, and et al. Incidence and prognostic impact of gastrointestinal bleeding after percutaneous coronary intervention for acute myocardial infarction Am J Cardiol 96 2005 173 176
95. S. Lin, R. Konstance, J. Jollis, and et al. The utility of upper endoscopy in patients with concomitant upper gastrointestinal bleeding and acute myocardial infarction Dig Dis Sci 51 2006 2377 2383
96. A. Shalev, D. Zahger, V. Novack, and et al. Incidence, predictors, and outcomes of upper gastrointestinal bleeding in patients with acute coronary syndromes Int J Cardiol 157 2012 386 390
97. P. Yachimski, and C. Hur Upper endoscopy in patients with acute myocardial infarction and upper gastrointestinal bleeding: results of a decision analysis Dig Dis Sci 54 2009 701 711
98. A.J. Hui, R.M. Wong, J.Y. Ching, and et al. Risk of colonoscopic polypectomy bleeding with anticoagulants and antiplatelet agents: analysis of 1657 cases Gastrointest Endosc 59 2004 44 48
99. H. Heidbuchel, P. Verhamme, M. Alings, and et al. European heart rhythm association practical guide on the use of new oral anticoagulants in patients with non-valvular atrial fibrillation Europace 15 2013 625 651
100. L.B. Gerson, B.F. Gage, D.K. Owens, and et al. Effect and outcomes of the ASGE guidelines on the periendoscopic management of patients who take anticoagulants Am J Gastroenterol 95 2000 1717 1724
101. S. Friedland, and R. Soetikno Colonoscopy with polypectomy in anticoagulated patients Gastrointest Endosc 64 2006 98 100
102. C.W. Ko, and J.A. Dominitz Complications of colonoscopy: magnitude and management Gastrointest Endosc Clin North Am 20 2010 659 671
103. D.A. Howell, S.L. Eswaran, B.J. Lowe, and et al. Use of hemostatic clips in patients undergoing colonoscopy in setting of Coumadin antithrombotic therapy [abstract] Gastrointest Endosc 63 2006 AB98
104. M. Sobrino-Faya, S. Martinez, M. Gomez Balado, and et al. Clips for the prevention and treatment of postpolypectomy bleeding (hemoclips in polypectomy) Rev Esp Enferm Dig 94 2002 457 462
105. S. Friedland, D. Sedehi, R. Soetikno, and et al. Colonoscopic polypectomy in anticoagulated patients World J of Gastroenterol 15 2009 1973 1976
106. H. Liaquat, E. Rohn, and D.K. Rex Prophylactic clip closure reduced the risk of delayed postpolypectomy hemorrhage: experience in 277 clipped large sessile or flat colorectal lesions and 247 control lesions Gastrointest Endosc 77 2013 401 407
107. N.D. Parikh, K. Zanocco, R.N. Keswani, and et al. A cost-efficacy analysis of prophylactic clip placement after endoscopic removal of large polyps Clin Gastroenterol Hepatol 11 2013 1319 1324
108. A. Repici, C. Hassan, D. De Paula Pessoa, and et al. Efficacy and safety of endoscopic submucosal dissection for colorectal neoplasia: a systematic review Endoscopy 44 2012 137 147
109. G. Kouklakis, A. Mpoumponaris, A. Gatopoulou, and et al. Endoscopic resection of large pedunculated colonic polyps and risk of postpolypectomy bleeding with adrenaline injection versus endoloop and hemoclip: a prospective, randomized study Surg Endosc 23 2009 2732 2737
110. N. Hussain, R. Alsulaiman, P. Burtin, and et al. The safety of endoscopic sphincterotomy in patients receiving antiplatelet agents: a case-control study Aliment Pharmacol Ther 25 2007 579 584
111. V. Kien-Fong, F. Chang, I. Doig, and et al. A prospective control study of the safety and cellular yield of EUS-guided FNA or Trucut biopsy in patients taking aspirin, nonsteroidal anti-inflammatory drugs, or prophylactic low molecular weight heparin Gastrointest Endosc 63 2006 808 813
112. M. Singh, N. Mehta, U.K. Murthy, and et al. Postpolypectomy bleeding in patients undergoing colonoscopy uninterrupted clopidogrel therapy Gastrointest Endosc 71 2010 998 1005
113. L.A. Feagins, R. Iqbal, W.V. Harford, and et al. Low rate of postpolypectomy bleeding among patients who continue thienopyridine therapy during colonoscopy Clin Gastroenterol Hepatol 11 2013 1325 1332
114. J.A. Richter, J.T. Patrie, R.P. Richter, and et al. Bleeding after percutaneous endoscopic gastrostomy is linked to serotonin reuptake inhibitors, not aspirin or clopidogrel Gastrointest Endosc 74 2011 22 34
115. M.L. Shiffman, M.T. Farrel, and Y.S. Yee Risk of bleeding after endoscopic biopsy or polypectomy in patients taking aspirin or other NSAIDs Gastrointest Endosc 40 1994 458 462
116. Y. Tsuji, K. Ohata, T. Ito, and et al. Risk factors for bleeding after endoscopic submucosal dissection for gastric lesions World J Gastroenterol 16 2010 2913 2917